| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $23.8M | -50.7% |
| SG&A Expense | $12.7M | -2.4% |
| Operating Income | -$39.9M | +34.8% |
| Pre-tax Income | -$38.3M | +37.8% |
| Income Tax | $0 | — |
| Net Income | -$38.3M | +37.8% |
| EPS (Basic) | -$1.44 | +40.7% |
| EPS (Diluted) | -$1.44 | +40.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.5M | -34.5% |
| Short-term Investments | $11.7M | -57.4% |
| Current Assets | $36.8M | -42.5% |
| Total Assets | $38.2M | -47.8% |
| Current Liabilities | $5.8M | -47.5% |
| Total Liabilities | $5.9M | -48.4% |
| Stockholders' Equity | $32.3M | -47.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.9M | +14.0% |
| Capital Expenditures | $196K | +0.0% |
| Investing Cash Flow | $22.3M | +80.3% |
| Financing Cash Flow | $2.9M | +467.3% |
| Free Cash Flow | -$37.1M | +14.0% |